{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:48:50Z","timestamp":1792900130335,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jtha.2024.10.014","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T11:58:58Z","timestamp":1729684738000},"page":"525-530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pazopanib in treatment of hereditary hemorrhagic telangiectasia-related epistaxis and gastrointestinal bleeding"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2581-1478","authenticated-orcid":false,"given":"Magdalena D.","family":"Lewandowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Betbadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.10.014_bib1","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3324\/haematol.2018.193003","article-title":"Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective","volume":"103","author":"Kritharis","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.10.014_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)","volume":"91","author":"Shovlin","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jtha.2024.10.014_bib5","first-page":"157","article-title":"Diagnosis and treatment of hereditary hemorrhagic telangiectasia","volume":"17","author":"Grigg","year":"2017","journal-title":"Ochsner J"},{"key":"10.1016\/j.jtha.2024.10.014_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.24832","article-title":"Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia","author":"Kasthuri","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2024.10.014_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.blre.2010.07.001","article-title":"Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment","volume":"24","author":"Shovlin","year":"2010","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2024.10.014_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccm.2016.04.013","article-title":"Hereditary hemorrhagic telangiectasia","volume":"37","author":"Parambil","year":"2016","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jtha.2024.10.014_bib9","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1182\/blood.V128.22.3776.3776","article-title":"Causes and severity of anemia in hereditary hemorrhagic telangiectasia","volume":"128","author":"Pahl","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.014_bib10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-0042-1743467","article-title":"Systemic antiangiogenic therapies for bleeding in hereditary hemorrhagic telangiectasia: a practical, evidence-based guide for clinicians","volume":"48","author":"Al-Samkari","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.10.014_bib11","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3324\/haematol.2020.261859","article-title":"An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study","volume":"106","author":"Al-Samkari","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.10.014_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10456-018-9646-1","article-title":"Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia","volume":"22","author":"Faughnan","year":"2019","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jtha.2024.10.014_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10456-021-09807-4","article-title":"Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia","volume":"25","author":"Parambil","year":"2022","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jtha.2024.10.014_bib14","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/lary.27129","article-title":"Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia","volume":"128","author":"Parambil","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jtha.2024.10.014_bib15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/jth.15715","article-title":"A\u00a0precision medicine approach to hereditary hemorrhagic telangiectasia and complex vascular anomalies","volume":"20","author":"Al-Samkari","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.014_bib16","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/M20-1443","article-title":"Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia","volume":"173","author":"Faughnan","year":"2020","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jtha.2024.10.014_bib17","first-page":"63","article-title":"Anti-VEGF agents and the risk of arteriothrombotic events","volume":"7","author":"Zarbin","year":"2018","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.jtha.2024.10.014_bib18","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.2147\/OTT.S103735","article-title":"Risk of venous and arterial thromboembolic events associated with anti-VEGF agents in advanced non-small-cell lung cancer: a meta-analysis and systematic review","volume":"9","author":"Zhang","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jtha.2024.10.014_bib19","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/jth.15354","article-title":"Thrombotic and bleeding risk of angiogenesis inhibitors in patients with and without malignancy","volume":"19","author":"Watson","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.014_bib20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40268-017-0203-y","article-title":"Does dose modification affect efficacy of first-line pazopanib in metastatic renal cell carcinoma?","volume":"17","author":"Grassi","year":"2017","journal-title":"Drugs R D"},{"key":"10.1016\/j.jtha.2024.10.014_bib21","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1248\/bpb.b19-00560","article-title":"Possibility for dose optimization of pazopanib from its plasma concentration in Japanese patients with cancer","volume":"43","author":"Tanaka","year":"2020","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jtha.2024.10.014_bib22","first-page":"53","article-title":"Pazopanib: approval for soft-tissue sarcoma","volume":"4","author":"Nguyen","year":"2013","journal-title":"J\u00a0Adv Pract Oncol"},{"key":"10.1016\/j.jtha.2024.10.014_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.jtha.2024.10.014_bib25","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/lary.20818","article-title":"An epistaxis severity score for hereditary hemorrhagic telangiectasia","volume":"120","author":"Hoag","year":"2010","journal-title":"Laryngoscope"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624006226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624006226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:12:09Z","timestamp":1762549929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624006226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1538783624006226"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.10.014","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pazopanib in treatment of hereditary hemorrhagic telangiectasia-related epistaxis and gastrointestinal bleeding","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}